Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome
Schwab, C., Nebral, K., Chilton, L., Leschi, C., Waanders, E., Boer, J., et al. (2017). Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia?. BLOOD ADVANCES, 1(19), 1473-1477 [10.1182/bloodadvances.2017006734].
Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Fazio, Grazia;Cazzaniga, Giovanni;
2017
Abstract
Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcomeFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Schwab_Intragenic PAXamp.pdf
accesso aperto
Tipologia di allegato:
Author’s Accepted Manuscript, AAM (Post-print)
Dimensione
1.03 MB
Formato
Adobe PDF
|
1.03 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.